Connection
Mark Eckardt to Precision Medicine
This is a "connection" page, showing publications Mark Eckardt has written about Precision Medicine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.104 |
|
|
|
-
Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Li Y, Nelson SD, Dry SM, Singh AS, Elliott IA, Russell TA, Eckardt MA, Yamamoto N, Hayashi K, Kimura H, Miwa S, Tsuchiya H, Eilber FC, Hoffman RM. Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy. J Cell Biochem. 2018 08; 119(8):6598-6603.
Score: 0.104